13738211000001109: Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Mirtazapine\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Mirtazapine\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Mirtazapine\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Mirtazapine\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Product containing mirtazapine in oral dose form (medicinal product form)\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing mirtazapine\Mirtazapine\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing mirtazapine\Mirtazapine\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing mirtazapine\Product containing mirtazapine in oral dose form (medicinal product form)\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzazepine\Product containing mirtazapine\Mirtazapine\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzazepine\Product containing mirtazapine\Mirtazapine\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzazepine\Product containing mirtazapine\Product containing mirtazapine in oral dose form (medicinal product form)\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Mirtazapine\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Mirtazapine\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Product containing mirtazapine in oral dose form (medicinal product form)\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antidepressant agent (product)\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Mirtazapine\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antidepressant agent (product)\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Mirtazapine\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antidepressant agent (product)\Medicinal product containing tetracyclic compound and acting as antidepressant agent (product)\Product containing mirtazapine\Product containing mirtazapine in oral dose form (medicinal product form)\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing mirtazapine in oral dose form (medicinal product form)\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Mirtazapine\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Mirtazapine\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)
\Medicinal product\Product containing autonomic agent\Product containing alpha adrenergic receptor antagonist\Product containing mirtazapine\Product containing mirtazapine in oral dose form (medicinal product form)\Product containing only mirtazapine in oral dose form (medicinal product form)\Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)\Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

48989501000001117 Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

111504001000001118 Mirtazapine 15mg orodispersible tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has excipient	Aspartame	false	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Is a	Product containing precisely mirtazapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has active ingredient	Mirtazapine	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral lyophilisate	false	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has excipient	Excipient not declared	false	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has specific active ingredient	Mirtazapine	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has dispensed dose form	Orodispersible tablet	false	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release orodispersible tablet	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet	Is pack of	False	Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) 30 tablet	Has AMP	True	Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
48989501000001117	Mirtazapine 15mg orodispersible tablets (Focus Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
111504001000001118	Mirtazapine 15mg orodispersible tablets (Advanz Pharma)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module